Friday 6 November 2026 Export REGN’s income statement to Excel — free account

Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.3 billion, up 0.99% from fiscal 2024.

Revenue: +36.3%
EPS: +36.0%
Free cash flow: +3.85%
Total debt: +0.06%

Quarter to September 2026, against a year earlier

905.02 2.12 +0.23%

Follow REGN

Alert me

Market cap: $93.4B
P/E: 19.3×
Fwd P/E: 19.2×
Dividend yield: 0.41%
F-score: 5/9
Altman Z: 7.49
Beneish M: −2.53
Dividend safety: 77/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
Piotroski F-Score Full definition →	7	6	5	5	+8 more TTM periods Free account
ROE Full definition →	14.95%	14.04%	14.55%	14.87%
ROA Full definition →	11.39%	10.83%	11.28%	11.50%
ROIC Full definition →	17.53%	9.34%	9.20%	8.82%
Return on Tangible Assets Full definition →	17.31%	23.56%	24.08%	24.00%
Average Days of Receivables Full definition →	163.72	154.26	140.21	146.10
Free Cash Flow per Share Full definition →	35.67	34.78	36.45	36.00
Free Cash Flow Full definition →	3,628.10	3,575.20	3,791.00	3,765.20
Capital Expenditures Full definition →	(1,217.90)	(1,106.10)	(1,221.70)	(1,213.70)
Other line items
Cash ROIC Full definition →	6.59%	8.58%	8.99%	8.85%
Accounts Receivable Turnover Full definition →	2.55	2.55	2.64	2.40
Accounts Payable Turnover Full definition →	0.59	2.50	2.66	2.43
Inventory Turnover Full definition →	0.78	0.75	0.73	0.67
Average Days of Payables Full definition →	1,097.64	179.90	162.59	163.15
Days of Inventory on Hand Full definition →	439.47	478.62	491.29	556.14
Tax Rate Full definition →	(0.15)	(0.16)	(0.14)	(0.14)
Research and Development Expense of Revenue Full definition →	39.04%	40.40%	40.66%	40.79%
Selling, General and Administrative Expense of Revenue Full definition →	16.35%	17.65%	18.20%	18.82%
Share Based Compensation of Revenue Full definition →	5.95%	6.35%	6.67%	6.93%
Interest Coverage Full definition →	104.16	69.37	75.61	81.69
Operating CF/Net income Full definition →	1.01	1.08	1.13	1.11
Depreciation/Fixed assets Full definition →	0.09	0.10	0.10	0.11
Capex/Depreciation Full definition →	(2.37)	(2.09)	(2.26)	(2.23)
Revenue per Share Full definition →	166.14	151.12	143.46	137.12
Operating CF per Share Full definition →	47.65	45.54	48.20	47.60
Capex per Share Full definition →	(11.98)	(10.76)	(11.75)	(11.60)
Capex to Sales Full definition →	0.07	0.07	0.08	0.08

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly